Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
1.500
-0.030 (-1.96%)
At close: May 20, 2024, 4:00 PM
1.480
-0.020 (-1.33%)
After-hours: May 20, 2024, 7:45 PM EDT

Sensei Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Selling, General & Admin
18.7719.8115.827.534.09
Upgrade
Research & Development
18.330.3821.6611.198.35
Upgrade
Other Operating Expenses
0000.740
Upgrade
Operating Expenses
37.0650.1937.4819.4512.44
Upgrade
Operating Income
-37.06-50.19-37.48-19.45-12.44
Upgrade
Interest Expense / Income
0.140.220.671.692.26
Upgrade
Other Expense / Income
-3.11-1.82-1.36-1.042.05
Upgrade
Pretax Income
-34.1-48.59-36.79-20.1-16.74
Upgrade
Net Income
-34.1-48.59-36.79-20.1-16.74
Upgrade
Preferred Dividends
0000.13.8
Upgrade
Net Income Common
-34.1-48.59-36.79-20.2-20.54
Upgrade
Shares Outstanding (Basic)
28312820
Upgrade
Shares Outstanding (Diluted)
28312820
Upgrade
Shares Change
-8.96%10.80%1618.88%338.85%-97.92%
Upgrade
EPS (Basic)
-1.22-1.58-1.33-12.53-55.92
Upgrade
EPS (Diluted)
-1.22-1.58-1.33-12.53-55.92
Upgrade
Free Cash Flow
-32.04-39.33-31.97-18.91-8.62
Upgrade
Free Cash Flow Per Share
-1.15-1.28-1.15-11.73-23.48
Upgrade
EBITDA
-31.25-45.83-35.44-18.2-14.41
Upgrade
Depreciation & Amortization
2.712.540.690.210.07
Upgrade
EBIT
-33.96-48.37-36.12-18.41-14.48
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).